(Q41377154)

30 September 2017

1 reference

title

Hepatitis C virus infection and autoimmunity (English)

1 reference

30 September 2017

1 reference

McMurray RW

1

1 reference

PubMed ID

9062950

30 September 2017

Elbourne K

series ordinal

2

1 reference

30 September 2017

1 February 1997

1 reference

Seminars in Arthritis and Rheumatism

30 September 2017

1 reference

30 September 2017

26

1 reference

30 September 2017

689-701

1 reference

30 September 2017

4

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Symptomatic myopathy in hepatitis C infection without interferon therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C infection and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Polymyositis, pulmonary fibrosis, and hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C genotypes: the key to pathogenicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Immunology of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C: diagnostic assays

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Discordant manifestations of hepatitis C in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus infection in patients with essential mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Mixed cryoglobulinemia and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Renal manifestations of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus-associated glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus infection and membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus in renal tissue of patients with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C as another possible cause of porphyria cutanea tarda and systemic lupus erythematosus: comment on the article by Kutz and Bridges.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Correlation of liver and skin histopathology with serology in a patient with cutaneous vasculitis and hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Images in clinical medicine. Vasculitis and cryoglobulinemia related to hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Cryoglobulinemia with vasculitis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Cutaneous vasculitis in a patient infected with hepatitis C virus. Detection of hepatitis C virus RNA in the skin by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Leukocytoclastic vasculitis associated with hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Anti-GOR and anti-thyroid autoantibodies in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Rheumatic manifestations of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Polyarthritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

A case of hepatitis C virus (HCV)-associated arthritis. Quantitative analysis of HCV RNA of the synovial fluid and the serum

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Development of Rheumatoid Arthritis after Chronic Hepatitis Caused by Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Polymyositis, dermatomyositis and inclusion-body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Symptomatic myopathy associated with interferon therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus and Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Absence of hepatitis C viral infection among patients with primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Mild sialoadenitis: a common finding in patients with hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Clonal B-cell expansions in peripheral blood of HCV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Hepatitis C virus and autoimmune chronic active hepatitis: closing the ring

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Autoimmune hepatitis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Detection of HCV-RNA in paraffin-embedded liver biopsies from patients with autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Interferon and hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Adult Still's disease associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

Quantitation of hepatitis C virus RNA in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980005-4

7 January 2021

10.1016/S0049-0172(97)80005-4

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9062950